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Abstract: The present study was conducted from July to August 2018 on milk samples taken at dairy
farms in the Northern Province and Kigali District of Rwanda in order to identify Staphylococcus spp.
associated with bovine intramammary infection. A total of 161 staphylococcal isolates originating
from quarter milk samples of 112 crossbred dairy cattle were included in the study. Antimicrobial
susceptibility testing was performed and isolates were examined for the presence of various resistance
genes. Staphylococcus aureus isolates were also analyzed for the presence of virulence factors, genotyped
by spa typing and further phenotypically subtyped for capsule expression using Fourier Transform
Infrared (FTIR) spectroscopy. Selected S. aureus were characterized using DNA microarray technology,
multi-locus sequence typing (MLST) and whole-genome sequencing. All mecA-positive staphylococci
were further genotyped using dru typing. In total, 14 different staphylococcal species were detected,
with S. aureus being most prevalent (26.7%), followed by S. xylosus (22.4%) and S. haemolyticus (14.9%).
A high number of isolates was resistant to penicillin and tetracycline. Various antimicrobial and
biocide resistance genes were detected. Among S. aureus, the Panton–Valentine leukocidin (PVL)
genes, as well as bovine leukocidin (LukM/LukF-P83) genes, were detected in two and three isolates,
respectively, of which two also carried the toxic shock syndrome toxin gene tsst-1 bovine variant.
t1236 was the predominant spa type. FTIR-based capsule serotyping revealed a high prevalence of
non-encapsulated S. aureus isolates (89.5%). The majority of the selected S. aureus isolates belonged to
clonal complex (CC) 97 which was determined using DNA microarray based assignment. Three new
MLST sequence types were detected.
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1. Introduction
Bovine mastitis is an important disease that affects the dairy sector and is one of the economically
most important diseases worldwide [1]. In Rwanda, it has a significant relevance because livestock
production is rapidly increasing [2]. One reason is that milk consumption and the demand for dairy
products are increasing with the rapid growth of the human population, from 3 million to 12 million
people [3] in the last 60 years.
Mastitis is an inflammation of the udder tissue and the mammary gland. It is usually caused
by bacteria invading through the teat canal. There are two types of mastitis: clinical and subclinical.
While cows with clinical mastitis show severe symptoms (e.g., fever, hot, painful and swollen udder)
and have visible changes in their milk (e.g., change of colour and consistency), cows with subclinical
mastitis produce less milk and have higher somatic cell counts in their milk [1]. The California Mastitis
Test (CMT) is a useful onsite method to confirm a bovine intramammary infection [4].
Staphylococci are the leading cause of mastitis [5,6], with S. aureus considered to be a major pathogen
associated with clinical mastitis and often-recurrent subclinical mastitis, even in well-managed dairy
herds. The primary mode of transmission is from cow-to-cow [1]. Coagulase-negative Staphylococcus
spp. (CoNS) are a heterogeneous group and are also known as common pathogens involved in bovine
mastitis. CoNS are primarily derived from the environment and are usually associated with a moderate
infection [1].
In Rwanda, udder infections are associated with contamination via hand-to-cow contact, clothing,
and other materials because hand milking is common. Poor milking hygiene is a risk factor not only for
mastitis, but also for teat-end damage [7]. Reduced milk production, high veterinary costs, as well as
prolific bacterial and antimicrobial contamination are the consequences of mastitis which can result
in significant economic losses for the farmers [8]. Recently, the Government of Rwanda launched a
development program, called Rwanda Vision 2020, with the main goal of transforming the country into
a knowledge-based middle-income country by modernizing its agriculture and livestock production [2].
Public veterinary services in Rwanda are provided by district and sector veterinary officers. They have
a limited capacity to support dairy farmers. Often, veterinary service workers receive poor training in
dairy management and are not equipped with adequate transportation to visit farms (approximately
3200 cattle/veterinary officers). Overall, access to veterinary services in rural areas is less developed
compared to urban areas [9].
In 2015, the first private animal clinic was established in the district of Musanze, called the New
Vision Veterinary Hospital (NVVH), to improve animal welfare and to provide veterinary services
(clinical and laboratory) as well as education based on collaboration with local and foreign universities
and organizations.
Nevertheless, the farmers’ access in Rwanda to veterinary drugs including antibiotics is possible
through local pharmacies [9]. A recent report explained that in parts of the country, high usage
of antibiotics in farm animals has become a common practice [9]. In a cross-sectional survey, the
use of antibiotics in farm animals was declared by the majority of respondents (97.4%), mainly for
disease prevention and growth promotion. More than half of the farmers (55.6%) were reported to
use non-prescribed antibiotics in animals. Although policies and laws regulating the antibiotic use in
humans and animals exist in Rwanda, antibiotics can be purchased without any medical or veterinary
prescription [9]. The irrational use of antibiotics in humans and animals is highly related to the increase
of antibiotic-resistant bacteria worldwide, including many classes of antimicrobial agents used in the
veterinary field [10].
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A recent study conducted in a hospital in Kigali, Rwanda assessing the antimicrobial susceptibility
patterns of bacteria from human patients, showed a high prevalence of antimicrobial resistance, also
among Staphylococcus spp. [11]. However, there is very limited information on the antimicrobial
susceptibility pattern of bacteria isolated from milk samples obtained from cases of bovine mastitis
in Rwanda. Recently, two studies showed a high prevalence of mastitis in the Northern Province
and the peri-urban areas of Kigali [12,13], but characterization of causative agents and antimicrobial
susceptibility testing, both phenotypic and genotypic, have not been performed. Thus, the present
study aims to fill these gaps by fully characterizing a collection of bovine staphylococci associated with
clinical and subclinical mastitis from the Northern Province and Kigali the District of Rwanda.
2. Results
From 303 CMT-positive milk samples collected from 112 crossbred milking cows, 161 non-repetitive
staphylococcal isolates comprising 14 staphylococcal species were recovered: S. aureus (n= 43), S. xylosus
(n = 36), S. haemolyticus (n = 24), S. sciuri (n = 14), S. chromogenes (n = 10), S. saprophyticus (n = 9),
S. epidermidis (n = 8), S. succinus (n = 5), S. capitis (n = 3), S. hominis (n = 2), S. devriesei (n = 2), S. auricularis
(n = 2), S. equorum (n = 2), and S. simulans (n = 1).
2.1. Antimicrobial Susceptibility Testing
All 161 isolates were susceptible to rifampicin, linezolid, and gentamicin. All but two were
susceptible to cefoxitin and chloramphenicol. A high number of the isolates was resistant to penicillin
(n = 73, 45.3%) and tetracycline (n = 63, 39.1%) (Tables 1 and 2). Twenty-three isolates were resistant to
clindamycin, ten to erythromycin, and six isolates were resistant to trimethoprim-sulfamethoxazole
(Tables 1 and 2).
The detection of resistance genes confirmed the phenotypic resistance profiles of the respective
isolates, detecting blaZ (n = 73, 45.3%), tet(K) (n = 45, 71.4%), both tet(K) and tet(L) (n = 17, 27.0%) and
all three tet(K), tet(L) and tet(O) (n = 1, 1.6%). Clindamycin-resistant isolates carried the following
resistance genes: erm(C) (n = 8, 34.8%), vga(A) (n = 2, 8.7%), erm(44) (n = 2, 8.7%), sal(A) (n = 2, 8.7%),
both vga(A) and sal(A) (n = 2, 8.7%), both erm(C) and sal(A) (n = 1, 4.3%), both sal(A) and erm(44)
(n = 1, 4.3%) and all three vga(A), sal(A) and lnu(A) (n = 2, 8.7%). In the erythromycin-resistant
isolates, two macrolide resistance genes were present: erm(C) (n = 6), and msr(A) (n = 4), whereas
the trimethoprim-sulfamethoxazole-resistant isolates carried both dfrA (also known as dfrS1) and
dfrD genes (n = 1), both dfrD and dfrG genes (n = 3) and all three dfrA, dfrD and dfrG genes (n = 2).
Two isolates were resistant to chloramphenicol, which was associated with the presence of fexA in a
S. xylosus and catpC221 in a S. saprophyticus isolate. The streptomycin resistance gene str was detected in
all 161 isolates, but its presence was not always associated with a higher MIC value (i.e., >8 mg/L) [14]
(Tables 1 and 2).
The mecA gene was detected in cefoxitin-resistant S. hominis and S. sciuri, whereas the mecC gene
could not be identified. One dru type (dt10cz) was detected in a S. hominis isolate, but the other
mecA-positive isolate was not dru-typeable.
None of the tested isolates carried the genes erm(A), erm(B), erm(F), erm(T), erm(43), erm(33), Isa(B),
vga(A)v vga(C), vga(E), vga(E)v, dfrK, tet(M), ant(6’)-la, cfr, catpC194, or catpC223.
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Table 1. Summarized molecular characterization, antimicrobial resistance and toxins profile of Coagulase-negative Staphylococcus isolates investigated.
Isolates Species Origin 1 Antimicrobial Resistance Profile
Biocide and Metal
Resistance Genes
Phenotype 2 MIC 3 of Streptomycin Genes Detected
2FR S. chromogenes M 1 32 4 str
3RL S. haemolyticus M 1 ERY, CLI 32 erm(C), str
4FR S. epidermidis M 1 PEN, TET 32 blaZ, tet(K), tet(L), str copB, qacAB, smr
4RR1 S. hominis M 1 BLA, FOX, ERY, TET, CIP ‹4 blaZ, mecA, msr(A), tet(K), tet(L), str cadD, arsA, qacAB, smr
4RR2 S. capitis M 1 PEN ‹4 blaZ, str cadD, arsA, qacAB, smr
7FL S. chromogenes M 2 ERY, CLI ‹4 erm(C), str
7RR S. epidermidis M 2 PEN, ERY, CLI, TET 32 blaZ, erm(C), tet(K), tet(L), str cadD, arsA, smr
8RL S. haemolyticus M 2 ERY, CLI 32 erm(C), str
13FLg S. xylosus M 3 PEN ‹4 blaZ, str cadD, copB
13FLw S. xylosus M 3 PEN, TET 32 blaZ, tet(K), tet(L), str cadD, arsA, smr
13FLw wh S. xylosus M 3 ERY ‹4 msr(A), str
13RR S. xylosus M 3 ERY, CLI, CHL ‹4 msr(A), fexA, str
14FL1 S. equorum M 3 ‹4 str
17RR S. equorum M 4 ‹4 str smr
18RLw1 S. epidermidis M 4 PEN, TET 32 blaZ, tet(K), tet(L), str cadD, arsA, qacAB, smr
18RLw2 S. haemolyticus M 4 PEN, TET 32 blaZ, tet(K), tet(L), str cadD, arsA, qacAB, smr
18RLg S. haemolyticus M 4 ‹4 str cadD, copB, arsA, smr
18FL S. auricularis M 4 16 str copB
24RLw S. xylosus M 5 ‹4 str cadD, smr
24RLg S. haemolyticus M 5 32 str
25FLw S. hominis M 5 PEN ‹4 blaZ, str cadD, arsA, qacAB, smr
25FLg S. xylosus M 5 PEN ‹4 blaZ, str
25FL3 S. xylosus M 5 ‹4 str cadD
25RR S. epidermidis M 5 PEN, TET 32 blaZ, tet(K), str
25RRg S. sciuri M 5 CLI ‹4 sal(A), str
26RL1 S. xylosus M 6 ‹4 str cadD
26RRw S. xylosus M 6 ‹4 str
26RRg S. xylosus M 6 ‹4 str
27RLg S. xylosus M 6 ‹4 str
28FRg S. xylosus M 7 ‹4 str
30FL S. devriesei M 8 TET 16 tet(K), str arsA
30RL S. devriesei M 8 PEN, TET 32 blaZ, tet(K), str arsA
30FR S. chromogenes M 8 PEN, TET ‹4 blaZ, tet(K), str
32FR S. chromogenes M 8 32 str
33RL S. chromogenes M 8 PEN, TET 32 blaZ, tet(K), str
33FR S. haemolyticus M 8 32 str
34RLw S. haemolyticus M 9 32 str cadD
35FR S. haemolyticus M 9 16 str arsA
35RRg S. haemolyticus M 9 16 str arsA
36FL S. haemolyticus M 9 TET 32 tet(K), tet(L), str
38FL S. auricularis M 9 ‹4 str cadD
Antibiotics 2020, 9, 1 5 of 17
Table 1. Cont.
Isolates Species Origin 1 Antimicrobial Resistance Profile
Biocide and Metal
Resistance Genes
Phenotype 2 MIC 3 of Streptomycin Genes Detected
42FR S. haemolyticus M 11 TET 32 tet(K), tet(L), str
43FRw S. xylosus M 11 TET ‹4 tet(K), str copB
44FL S. xylosus M 11 ‹4 str
46FR S. epidermidis M 11 PEN 32 blaZ, str cadD
47RRg S. chromogenes M 12 32 str qacAB, smr
50RL S. sciuri M 12 CLI ‹4 erm(44), str
50RR S. sciuri M 12 CLI ‹4 erm(44), sal(A) str
51RR S. xylosus M 12 TET ‹4 tet(K), str
52FL S. haemolyticus K PEN, CLI, TET 32 blaZ, erm(C), tet(K), tet(L), str cadD, copB, qacAB, smr
52FR S. haemolyticus K ‹4 str cadD, copB, arsA
53FL S. haemolyticus K PEN, CLI, TET 32 blaZ, tet(K), str copB
53RL S. haemolyticus K CLI, TET 32 vga(A), sal(A), Inu(A), tet(K), tet(L), str qacAB, smr
53RR S. haemolyticus K CLI, TET 32 vga(A), sal(A), Inu(A), tet(K), tet(L), str qacAB, smr
54FR S. haemolyticus K CLI 32 vga(A), str
54RRw S. haemolyticus K PEN, CLI, SXT, TET 32 blaZ, dfrA, dfrD, tet(K), str
54RRg S. xylosus K 32 str smr
55RR1 S. epidermidis K PEN, TET ‹4 blaZ, tet(K), str copB, arsA, qacAB, smr
55RR2 S. capitis K PEN ‹4 blaZ, str copB, arsA, smr
56RL S. sciuri K CLI ‹4 vga(A), sal(A), str
57FLw S. capitis K PEN, TET ‹4 blaZ, tet(K), tet(L), str cadD, smr
57FRw S. haemolyticus K CLI, TET 32 tet(K), tet(L), str copB, smr
58FL S. haemolyticus K CLI, TET 32 erm(C), sal(A), tet(K), tet(L), str smr
58FR S. haemolyticus K CLI, TET 32 vga(A), tet(K), tet(L), str
58RR S. xylosus K ‹4 str
61RR S. xylosus K SXT, TET ‹4 dfrA, dfrD, dfrG, tet(K), tet(L), str smr
61RL S. xylosus K TET 32 tet(K), str copB, smr
62FR S. xylosus K ‹4 str copB
62RR S. haemolyticus K ‹4 str cadD
63RL S. sciuri K PEN ‹4 blaZ, str
64RR S. epidermidis K PEN, SXT, TET 32 blaZ, dfrA, dfrD, dfrG, tet(K), tet(L), tet(O), str copB, arsA, smr
65RL S. haemolyticus K PEN, ERY, SXT, TET 32 blaZ, msr(A), dfrD, dfrG, tet(K), str cadD, copB, arsA
66RL S. xylosus K PEN, TET ‹4 blaZ, tet(K), str qacAB
66RR S. epidermidis K PEN, TET, TEC 32 blaZ, tet(K), str cadD, smr
67RL S. chromogenes K 32 str
68RL S. chromogenes K 32 str
68RR S. xylosus K PEN ‹4 blaZ, str
70RLw S. simulans K PEN 32 blaZ, str copB
70FR S. sciuri K FOX ‹4 mecA, str
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Table 1. Cont.
Isolates Species Origin 1 Antimicrobial Resistance Profile
Biocide and Metal
Resistance Genes
Phenotype 2 MIC 3 of Streptomycin Genes Detected
1stCowFL S. chromogenes M 13 ‹4 str
2ndCowRL S. xylosus M 13 TET ‹4 tet(K), str
73RL S. sciuri M 14 PEN ‹4 blaZ, str
73RR S. xylosus M 14 ‹4 str
78FR S. xylosus M 17 ‹4 str
78RL S. sciuri M 17 CLI ‹4 vga(A), sal(A), str
81 RR S. haemolyticus M 18 PEN ‹4 blaZ, str cadD
82RL S. sciuri M 18 CLI ‹4 erm(44), str
82RR S. saprophyticus M 18 TET, CHL 4 tet(K), catpC221, str
84RR S. saprophyticus M 18 TET ‹4 tet(K), str copB
85FR S. xylosus M 19 TET 8 tet(K), str
85FL S. saprophyticus M 19 TET 8 tet(K), str copB, arsA, qacAB
86FR S. saprophyticus M 19 ‹4 str copB
87FL S. saprophyticus M 19 TET 4 tet(K), str copB
89FR S. sciuri M 20 ‹4 str
89RR S. xylosus M 20 PEN ‹4 blaZ, str
94RR S. succinus M 21 PEN ‹4 blaZ, str copB
94RL S. sciuri M 21 PEN ‹4 blaZ, str
95FR S. xylosus M 21 ‹4 str
95RR S. xylosus M 21 ‹4 str
96FR S. xylosus M 21 TET ‹4 tet(K), str qacAB
96RR S. xylosus M 21 ‹4 str
97RL S. sciuri M 21 ‹4 str
97RR S. xylosus M 21 SXT ‹4 dfrD, dfrG, str
98RR S. succinus M 21 PEN ‹4 blaZ, str cadD
99FR S. xylosus M 22 ‹4 str
99RL S. xylosus M 22 ‹4 str copB
103RR S. chromogenes M 22 PEN 32 blaZ, str
104RR S. succinus M 23 ‹4 str smr
104RL S. succinus M 23 PEN ‹4 blaZ, str cadD, arsA, smr
105RL S. succinus M 24 ‹4 str cadD, smr
106FL1 S. saprophyticus M 24 ‹4 str copB
107RL S. saprophyticus M 25 PEN 16 blaZ, str copB
108FL S. saprophyticus M 25 SXT ‹4 dfrD, dfrG, str arsA
110RL S. xylosus M 26 ‹4 str copB, smr
110RR1 S. saprophyticus M 26 ‹4 str copB, arsA
110RR2 S. xylosus M 26 ‹4 str copB
111RL S. sciuri M 26 PEN, CLI ‹4 sal(A), blaZ, str
113RL S. sciuri M 26 16 str
1 Origin: M = Musanze Farm, K = Kigali Farm.2 Phenotype: PEN = penicillin; CIP = ciprofloxacin; CHL = chloramphenicol; CLI = clindamycin; ERY = erythromycin; SXT =
trimethoprim-sulfamethoxazole; TET = tetracycline; FOX = cefoxitin, TEC = teicoplanin. 3 mg/L. 4 32 or higher (mg/L).
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Table 2. Summarized molecular characterization, antimicrobial resistance and toxin profile of the Staphylococcus aureus isolates investigated.



















1FR * M 1 ST97 t1236 PEN 32 6 blaZ, str not tested NEG 8 POS 8 hla, hlb, hld NEG icaC, icaD clfA, fib, fnbA, fnbB, sasG
6RR * M 2 CC152 ST152 t458 ERY, CLI 32 erm(C), str CP5 NEG POS hla, hlb, hld lukS-PV/lukF-PV icaA, icaD clfA, clfB, cna, fnbA, fnbB
11RR * M 3 ST97 t1236 PEN ‹4 blaZ, str smr nt NEG POS hla, hlb, hld NEG icaC, icaD clfA, fib, fnbA, fnbB, sasG
24RR * M 5 CC3666 ST5477 t1236 PEN, TET 32 blaZ, tet(K),tet(L), str nt POS NEG hla, hld lukD icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
tsst-1, sei, sem,
sen, seo, seu
26FR M 6 t1236 PEN 32 blaZ, str not tested not tested not tested not tested not tested not tested not tested
26FL M 6 CC97 t1236 PEN 16 blaZ, str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
26RL2 M 6 nt 7 PEN 32 blaZ, str nt not tested not tested not tested not tested not tested not tested
27FL M 6 t1236 PEN 32 blaZ, str nt not tested not tested not tested not tested not tested not tested sec
27RLw M 6 CC97 t1236 PEN ‹4 blaZ, str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
27RR M 6 t1398 TET 4 tet(K), str nt not tested not tested not tested not tested not tested not tested
36RR M 9 CC97 t1236 PEN 32 blaZ, str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
37RR M 9 t9432 PEN, TET ‹4 blaZ, tet(K), str nt not tested not tested not tested not tested not tested not tested
39FR M 10 CC97 t2112 PEN 8 blaZ, str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
40FL M 10 CC97 t1236 PEN, TET 32 blaZ, tet(K), str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
43RL M 11 CC97 t18835 PEN, TET 32 blaZ, tet(K), str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
44RR M 11 CC3591 t458 ‹4 str smr CP8 POS NEG hla, hlb, hld lukM/lukF-PV (P83) icaA, icaC, icaD clfA, clfB, fib, cna, fnbA
63FL K CC152 ST152 t355 ERY, CLI 32 erm(C), str not tested NEG POS hla, hlb, hld lukS-PV/lukF-PV icaA, icaD clfA, clfB, cna, fnbA, fnbB
71FL M 14 CC3591 ST5475 t355 TET 32 tet(K), str nt POS NEG hla, hlb, hld NEG icaA, icaC, icaD clfA, clfB, fib, cna, fnbA sem, seo
74FL M 14 t1236 PEN, TET 32 blaZ, tet(K), str nt not tested not tested not tested not tested not tested not tested
75FR M 15 CC97 t10103 PEN, TET 32 blaZ, tet(K), str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
75FL M 15 t1236 PEN, TET 32 blaZ, tet(K), str nt not tested not tested not tested not tested not tested not tested
76RR M 16 CC3591 ST5476 t458 ‹4 str CP8 POS NEG hla, hlb, hld lukM/lukF-PV (P83) icaA, icaC, icaD clfA, clfB, fib, cna, fnbA
77RR M 17 CC3591 t458 16 str CP8 POS NEG hla, hlb, hld lukM/lukF-PV (P83) icaA, icaC, icaD clfA, clfB, fib, cna, fnbA
78FL M 17 CC97 t1236 PEN, TET 32 blaZ, tet(K), str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
80RL M 18 t380 PEN, TET 32 blaZ, tet(K), str nt not tested not tested not tested not tested not tested not tested sec
82FL M 18 t380 PEN, TET ‹4 blaZ, tet(K), str not tested not tested not tested not tested not tested not tested not tested
83RL M 18 CC97 t380 PEN 32 blaZ, str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
84RL M 18 t380 PEN, TET 32 blaZ, tet(K), str nt not tested not tested not tested not tested not tested not tested
85RR M 19 CC97 t1236 PEN, TET 32 blaZ, tet(K), str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
85RL M 19 t10103 PEN, TET 32 blaZ, tet(K), str qacAB nt not tested not tested not tested not tested not tested not tested
86FL M 19 t1236 PEN, TET 32 blaZ, tet(K), str nt not tested not tested not tested not tested not tested not tested
87FR M 19 t10103 PEN, TET 32 blaZ, tet(K), str nt not tested not tested not tested not tested not tested not tested
87RL M 19 t1236 PEN, TET 32 blaZ, tet(K), str nt not tested not tested not tested not tested not tested not tested
90FR M 20 t9432 PEN, TET 32 blaZ, tet(K), str nt not tested not tested not tested not tested not tested not tested
90FL M 20 t9432 PEN, TET 32 blaZ, tet(K), str not tested not tested not tested not tested not tested not tested not tested
91FL M 20 CC97 t9432 PEN 32 blaZ, str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
100RR M 22 CC97 t1236 PEN, TET ‹4 blaZ, tet(K), str qacAB nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
100RL M 22 CC97 t1236 PEN, TET ‹4 blaZ, tet(K), str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
101RR M 22 CC97 t10103 PEN 32 blaZ, str nt NEG POS hla, hlb, hld lukD, lukE icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG
101RL M 22 t10103 PEN 32 blaZ, str nt not tested not tested not tested not tested not tested not tested
103FR M 22 CC3666 t18853 PEN, TET 32 blaZ, tet(K), str smr nt POS NEG hla, hlb, hld lukD icaA, icaC, icaD clfA, clfB, fib, fnbA, fnbB, sasG tsst-1, sei, sem,sen, seo, seu
104FR M 23 t1236 PEN, TET 32 blaZ, tet(K), str smr nt not tested not tested not tested not tested not tested not tested
106FL2 M 24 t18835 PEN, TET 32 blaZ, tet(K), str qacAB nt not tested not tested not tested not tested not tested not tested
1 Origin: M = Musanze Farm, K = Kigali Farm. 2 clonal complex. 3 sequence type. 4 Phenotype: PEN = penicillin; CIP = ciprofloxacin; CHL = chloramphenicol; CLI = clindamycin; ERY =
erythromycin; SXT = trimethoprim-sulfamethoxazole; TET = tetracycline; FOX = cefoxitin, TEC = teicoplanin. 5 mg/L. 6 32 or higher (mg/L); 7 Capsule serotype: nt = non-typable; CP5 =
Serotype 5; CP8 = Serotype 8. 8 NEG = negative, POS = positive. * analysed by whole-genome sequencing.
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2.2. Metal and Biocide Resistance Testing
Biocide resistance profiling revealed that 33 isolates carried the smr gene, most frequently the
species S. haemolyticus (n = 7), S. epidermidis (n = 6), S. xylosus (n = 6) and S. aureus (n = 4). Seventeen
isolates carried the qacAB gene, where the predominant species were S. haemolyticus (n = 4), S. epidermidis
(n = 3), S. aureus (n = 3), S. xylosus (n = 2) and S. hominis (n = 2). Furthermore, the presence of the
following metal resistance genes was confirmed: cadD (n = 25), copB (n = 27) and arsA (n = 21). The most
prevalent species, which carried the cadD gene, was S. haemolyticus (n = 8), followed by S. xylosus
(n = 5) and S. epidermidis (n = 4). A significant carriage rate of copB was shown by S. saprophyticus
(n = 7) and S. xylosus (n = 7). The arsA gene was mostly detected in the species S. haemolyticus (n = 6),
S. epidermidis (n = 4) and S. saprophyticus (n = 3). However, none of the isolates carried the czrC gene
(Tables 1 and 2) and all S. aureus isolates were negative for metal resistance genes.
2.3. Additional Characterization of S. aureus Isolates
Among S. aureus, the lukS-PV and lukF-PV genes coding for the Panton–Valentine leukocidin
(PVL) were detected in two isolates, the bovine leukocidin gene lukM/lukF-P83 was present in three
isolates. The tsst-1 gene was detected in two isolates and was solely found in combination with
enterotoxin genes. The enterotoxin genes sei (n = 2), sem (n = 3), sen (n = 2), seo (n = 3) and seu (n = 2),
that belonged to the egc cluster, and sec (n = 2) were detected. Staphylococcal enterotoxin genes sea, seb,
sed, see, seg, seh, sej, sek, sel, seq, ser and the gene for the enterotoxin like protein CM14 could not be
detected in the S. aureus isolates (Table 2).
Ten different spa types were identified among the tested isolates. The spa type t1236 (n = 18)
was predominant, followed by t10103 (n = 5), t380 (n = 4) and t9432 (n = 4), t458 (n = 4), t355 (n = 2)
and singletons t2112 and t1398. Two new spa types were detected: t18835 (n = 2, repeat order
26-23-34-34-34-34-33-34) and t18853 (n = 1, repeat order 04-20-17-24-17).
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Figure 1. FTIR spectroscopy-based cluster of S. aureus isolate from quarter milk samples of cows with
mastitis. CP = capsule type; NT = none typeable.
FTIR-based capsule serotyping revealed a high prevalence of non-encapsulated S. aureus isolates
(n = 34; 89.5%) and the remaining isolates produced a capsule of either serotype 8 (CP8, n = 3) or 5 (CP5,
n = 1). Hierarchical cluster analysis of spectral FTIR data grouped the S. aureus isolates into two main
Antibiotics 2020, 9, 1 9 of 17
clusters (A; n = 3 and B; n = 35; Figure 1). Cluster A could be assigned to CP 8 while non-typeable (NT)
isolates were grouped into the main cluster B, except one isolate assigned to CP5 (B2.2). All NT isolates
were found to harbour either the cap8- (B2.1, n = 4) or cap5-specific allele (B1.1, n = 2 and B1.2, n = 28).
No association between the origin of the samples and the FTIR cluster alignment was detectable.
Among the selected S. aureus isolates examined using DNA microarray and whole-genome
sequencing, different resistance genes (blaZ, erm(C), tet(K)) and virulence genes (hla, hlb, hld, lukD, lukE,
lukM, lukF-P83, icaA, icaC, icaD, bap, clfA, clfB, fib, can, fnbA, fnbB, sasG) could be found (Table 2). Four
different clonal complexes (CC) were identified. Here, the CC97 isolates (n = 14) clustered into FTIR
cluster B1, the CC3591 isolates (n = 4) into clusters A and B2.1, the CC3666 isolates (n = 2) into cluster
B2.1 and one isolate of CC152 into cluster B2.2. Three S. aureus that were selected for MLST revealed
the new sequence types ST5475 (199-805-44-430-447-192-733), ST5476 (199-806-741-2-447-192-734) and
ST5477 (6-55-45-2-109-14-741).
3. Discussion
Clinical and subclinical mastitis can be one of the serious consequences of poor milking hygiene [5,7].
Previous studies have shown that the prevalence of mastitis within the East African region is high and
that CoNS are common pathogens in bovine mastitis [5,15–17]. This finding was also confirmed in
this study.
In the present study, S. aureus was the predominant Staphylococcus spp., which is in accordance
with studies from other countries in that region, such as Tanzania, and Kenya [16,18]. Another study
from Uganda showed that the predominant Staphylococcus spp. were from the CoNS group, but they
were not further characterized to the species level [15]. Among CoNS, S. chromogenes, S. haemolyticus,
S. epidermidis, S. simulans and S. xylosus are usually the most common isolated species associated with
bovine mastitis [19,20]. However, distribution of CoNS species has shown to be herd-specific and
influenced by different management practices that can vary between countries [1,20].
Penicillin resistance is probably the best known antimicrobial resistance property of S. aureus
and its frequency in the current study is in accordance with other studies that examined antibiotic
susceptibility patterns of staphylococci isolated from cases of bovine mastitis in other parts of Africa as
well as in Germany and Finland [16,21–24]. Penicillin is a routinely used antimicrobial agent for the
prevention and treatment of mastitis in dairy cows in Rwanda [9] and the blaZ gene was present in all
73 penicillin-resistant Staphylococcus spp. isolates (100%) in the current study. This gene encodes a
narrow-spectrum β-lactamase which confers penicillin resistance [10,25].
Tetracycline belongs to the broad-spectrum antimicrobial agents and is also an often-used
antimicrobial agent in farm animals in Rwanda [9]. Resistance to tetracyclines is frequently mediated
by the genes tet(K) and tet(L), which code for active eﬄux mechanisms, and occasionally by tet(M)
and tet(O), which encode ribosome-protective proteins [10]. In the present study, tet(K) was found
in all tetracycline-resistant staphylococci (100%), followed by tet(L) (28.6%) and tet(O) (1.6%), while
tet(M) was not detected in any of the tetracycline-resistant isolates. In a study from Tunisia, 10.3% of
the staphylococcal isolates (n = 68) showed resistance to tetracycline and this resistance was always
encoded by the tet(K) gene [26]. In another study from Germany, the tet(M), tet(K) and tet(L) genes
were investigated among resistant S. aureus sisolates, originating from cases of bovine clinical mastitis
(n = 25) and from farm personnel (n = 2), and tet(M) was found in 100%, tet(K) in 92.6% and tet(L) in
40.7% of the isolates [23].
Two S. haemolyticus and one S. xylosus isolate exhibited phenotypic resistance to clindamycin
although a corresponding resistance gene was not detected. Whole genome sequencing of these isolates
in a future study will hopefully clarify the genetic basis for the observed lincosamide resistance. Another
problem detected in this study was the phenotypic assessment of streptomycin resistance. All isolates
carried the resistance gene str, but MICs to streptomycin varied between ≤4 and 32 mg/L. Neither
CLSI, nor EUCAST provide clinical breakpoints for streptomycin and staphylococci. The sequenced str
amplicons obtained from staphylococcal isolates with low streptomycin MICs as well as from those
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with high streptomycin MICs did not differ in their sequences (author’s own observation). Again,
whole genome approaches may help to clarify the situation.
Quaternary ammonium compounds (QACs)-based antiseptics are frequently used worldwide and
this prevailing usage can lead to bacterial resistance against these substances [27,28]. In the current
study, the antiseptic resistance genes qacAB and smr were examined. The smr gene was found more
frequently than the qacAB genes. These results were similar to those of a study from Norway assessing
the resistance to QACs in bacteria from milk samples obtained from 127 dairy cattle herds and 70 goat
herds, where the smr gene was present in 64.2% and the qacAB gene in 28.5% of the isolates (n = 42) [28].
Studies about the bacterial resistance to QACs in staphylococci originating from bovine milk in Africa
are scarce. One study from three African countries (Angola, São Tomé and Príncipe, Cape Verde), where
a total of 301 S. aureus isolates were investigated, reported an intermediate prevalence for the qacAB
gene (40.5%) and a low prevalence for the smr gene (3.7%) [29].
Many other substances with antimicrobial effects, including metal-containing compounds, are used
in food-animal production, where they can contribute to the selection of isolates among staphylococcal
species [30]. According to a study from 2017 on cattle production in East Rwanda, only 3.6% (n = 13) of
the farmers practiced supplementary feeding [2]. However, in the present study, conducted in Northern
parts of Rwanda and Kigali, 51 (31.5%) of the bacterial isolates carried at least one heavy metal resistance
gene. Heavy metal resistance genes occurred most frequently in S. haemolyticus (n = 12) followed by
S. xylosus (n = 11) and S. saprophyticus (n = 8). In another study, S. haemolyticus and S. epidermidis carried
the most heavy metal resistance genes [31], but the isolates in the current study did not show a high rate
of heavy metal resistance genes, which is possibly explained by the different geographical collection sites.
The vast majority of the collected S. aureus mastitis isolates in this study were non-encapsulated
as shown by spectroscopic capsule serotyping. This is in concordance with several previous reports
showing a high prevalence of non-encapsulated mastitis isolates in Argentina, USA and Austria [32–34].
Moreover, non-encapsulation was associated with high within-herd prevalence of S. aureus-based
persistent, contagious bovine intramammary infections [35]. Indeed, this study provides further
evidence that loss of capsule expression is a key phenotypic feature associated with bovine mastitis, a
primarily chronic infection [36]. Out of the 38 FTIR-typed isolates, 22 were selected for clonal complex
(CCs) identification using DNA microarray-based technology and three of them (two CC3591 and one
CC3666) were genotyped by MLST. The four CCs (CC97, CC3591, CC3666, CC152) identified were
relatively distinctive for one of the FTIR clusters, also seen by Kümmel et al. in 2016 [34], though no
connection to one particular farm could be found. Most isolates were assigned to the common bovine
lineage CC97, indicating predominance of this cattle-adapted clone, which has already been reported
from bovine mastitis cases worldwide including Europe, Japan, Algeria, and South Africa [37–40].
The most predominant spa type among S. aureus in the present study was t1236. This is a spa
type within ST97 and associated with CC97 along with the other spa types t2112, t380, and t10103,
commonly found among S. aureus from neighbouring Uganda [41]. The spa type t1236 has also been
detected among S. aureus from bovine milk in Japan, reported as ST97 [38]. The spa type t458, which
was found in four isolates in the current study, has been detected in S. aureus from a case of bovine
mastitis in China [42] and from bovine milk in Japan [38]. Many African studies (Democratic Republic
of the Congo, Gabon, Ghana, Kenya, Nigeria and Uganda) reported the presence of spa type t355 in
S. aureus from humans [43–48], which was also identified in three isolates in the current study.
Five S. aureus isolates carried PVL genes, which is of interest due to the common association
with soft tissue and skin infections and the reported human to cow transmission of S. aureus [49,50].
The PVL genes code for proteins which are responsible for cytotoxic activity, especially leukocytes are
affected [51]. The lukS-PV and lukF-PV genes (PVL genes) were mainly detected in S. aureus of human
origin [52], but have also been reported in isolates from bovine mastitis cases in Africa suggesting
human to cow transmission of the respective isolates [41,50]. These human-associated genes were
also detected in two S. aureus ST152 isolates obtained from two cows kept in two different farms in
this study (Table 2). The LukM/LukF-PV(P83) protein only kills bovine neutrophils and is common
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in S. aureus isolated from bovine mastitis [51,52]. In a study from North-Western Ethiopia, however,
this bovine-related leukocidin was detected in a low percentage (4%) and the isolates did not belong
to the common ST97 [50]. This was in line with the results of the current study where this gene
was only present in three of the further selected S. aureus isolates, which belonged to ST5476 and to
CC3591. Previous reports demonstrated that isolates belonging to ST97 may also be negative for the
bovine-related leukocidin [38,53].
In the present study, the tsst1 gene was detected in two isolates and further classified as bovine
variant of tsst1 which has been described in previous studies dealing with S. aureus associated with
bovine mastitis [39,50–55].
4. Materials and Methods
4.1. Isolation and Identification of Staphylococci
Isolation of Staphylococcus spp. was conducted from July to August 2018 from CMT-positive
milk samples originating from 112 crossbred dairy cows kept on 28 farms in the Northern Province
and the Kigali District of Rwanda. Farms were selected for sampling based on farmers’ reports on
decreased milk production of multiple cows. Before sampling, a short clinical check was performed
on each selected cow, including palpation of the udder, examination of the milk and measuring the
body temperature. Afterwards, CMT was performed, which can indicate the presence of mastitis [4].
Collected milk samples were transported to the microbiological laboratory of NVVH, and bacteriological
analyses were performed. Milk samples were cultivated on blood agar (Blood Agar Base, Rapid Labs,
UK) supplemented with 5% of defibrinated sheep blood. After incubation at 37 ◦C for 24 h, each colony
representing a distinct colony morphotype, but showing typical staphylococcal colony appearance,
was regrown on the same medium. Pure staphylococcal cultures were stored at 4 ◦C until they were
transported to the diagnostic laboratory of the Institute of Microbiology at the University of Veterinary
Medicine, Vienna for further examination. All isolates were regrown on BD Columbia III agar plates
with 5% Sheep Blood (Becton Dickinson, Heidelberg, Germany), and identified by matrix-assisted laser
desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Bruker Daltonik, Bremen,
Germany). If MALDI-TOF MS yielded ambiguous results, rpoB gene sequencing was performed [56].
4.2. Antimicrobial Susceptibility Testing and Detection of Resistance Genes and SCCmec-Associated Direct
Repeat Unit (dru) Typing
Antimicrobial susceptibility testing was performed by agar disk diffusion according to CLSI
standards (CLSI, 2018) for the following antimicrobial agents (µg/disk): tetracycline (30), ciprofloxacin
(5), erythromycin (15), clindamycin (2), penicillin (10 IU), cefoxitin (30), chloramphenicol (30),
gentamicin (10), rifampicin (5), linezolid (30), and trimethoprim-sulfamethoxazole (1.25 + 23.75).
In addition, minimum inhibitory concentrations (MICs) of streptomycin were established by the
agar dilution method on Mueller–Hinton agar in serial twofold dilutions (4, 8, 16, and 32 µg/mL) in
accordance with the CLSI document M7-A9 (CLSI, 2012).
Staphylococcal DNA was extracted as described previously [57]. PCR was used to detect the
presence of the following antibiotic resistance genes: blaZ (confers resistance to penicillins except
isoxazolyl-penicillins) [25]; mecA, mecC (confer resistance to all penicillins and cephalosporins approved
for veterinary use) [58]; erm(A), erm(B), erm(C), erm(F), erm(T), erm(33), erm(43), and erm(44) (confer
resistance to macrolides, lincosamides, and streptogramin B), vga(A), vga(A)v, vga(C), vga(E), vga(E)v
and sal(A) (confer resistance to streptogramin A, lincosamides and pleuromutilins); Isa(B) and Inu(A)
(confer elevated MICs or resistance to lincosamides) [23,59–68]; msr(A) (confers resistance to macrolides
and streptogramin B) [57]; cfr (confers resistance to all phenicols, lincosamides, oxazolidinones,
pleuromutilins, and streptogramin A) [69]; fexA (confers resistance to all phenicols) [69]; catpC194,
catpC221, and catpC223 (confer resistance to non-fluorinated phenicols, e.g., chloramphenicol) [70];
ant(6′)-Ia and str (confer resistance to the aminoglycoside streptomycin) [14]; dfrA, dfrD, dfrG, and dfrK
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(confer resistance to trimethoprim) [57,71]; tet(K) and tet(L) (confer resistance to tetracyclines except
minocycline and glycylcyclines) [57]; tet(O) and tet(M) (confer resistance to tetracyclines, including
minocycline, but excluding glycylcyclines) [72].
PCRs targeting qacAB (confers high-level resistance to antiseptics) and smr (confers low-level
resistance to antiseptics) genes were performed as previously described [27]. Furthermore, PCRs were
performed for detecting the presence of the following heavy metal resistance genes: cadD, copB, arsA
and czrC [30,31].
The mecA-positive isolates were further examined by SCCmec-associated direct repeat unit (dru)
typing [73].
4.3. Additional Characterization of S. aureus Isolates
All S. aureus isolates were examined by different PCRs targeting Panton–Valentine Leukocidin
(PVL) genes, staphylococcal enterotoxins (SE), and the toxic shock syndrome toxin 1 (TSST1) as
previously described [58]. Furthermore, S. aureus were genotyped by spa typing [57].
Using Fourier Transform Infrared (FTIR) spectroscopy, all isolates were further phenotypically
subtyped based on their surface glyco structural composition that included the determination of the
capsular polysaccharide (CP) expression [74,75]. On FTIR based clustering, 22 S. aureus isolates were
selected and further analysed using DNA microarray-based technology to detect over 300 different
target sequences including antimicrobial resistance and virulence-associated genes, species-specific
genes, and SCCmec-associated genes [76]. Three isolates were genotyped using MLST as previously
described [57]. In addition, whole-genome sequencing, as well as contig assembly and annotation, and
comparative genomics were conducted as previously described using Seqsphere+ (Ridom, Münster,
Germany) [77–79]. The same software was used for cgMLST [77]. The genomes of four S. aureus isolates
were submitted under SUB6695668 in the NCBI BioProject database.
5. Conclusions
The present study is the first investigating not only the phenotypic but also the genotypic resistance
to antimicrobial agents and biocides in Staphylococcus spp. isolated from cases of bovine mastitis in
Rwanda. It improves our knowledge about the high diversity of Staphylococcus spp., their occurrence
in the study area and about the presence of resistance genes.
Due to the rising importance of the dairy production system in Rwanda, improvements in the
prevention and treatment of bovine mastitis are critical to prevent misuse of antimicrobial agents and
the increase of resistance to antimicrobial agents and biocides, which is in accordance with the ‘one
world, one health’ principle [80].
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